Characteristics and mechanisms of T-cell senescence: A potential target for cancer immunotherapy

Han Wu1, Junru Li1, Zhen Zhang1,2

  • 1Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

PubMed

Insights

Immunosenescence, the aging immune system, impairs T cells. This review explores T-cell changes, their role in cancer, and strategies to target senescent T cells for better health and cancer immunotherapy.

Area of Science:

  • Immunology
  • Gerontology
  • Oncology

Background:

  • Immunosenescence describes the aging of the immune system, characterized by functional decline, especially in T cells.
  • Age-associated T-cell alterations are studied in healthy aging, but senescent T cells also appear in younger individuals with diseases like cancer.

Purpose of the Study:

  • To review recent advancements in understanding age-associated T-cell alterations and markers.
  • To elucidate the mechanisms driving T-cell senescence.
  • To explore the interplay between senescent T cells and the tumor microenvironment.

Main Methods:

  • Literature review of recent studies on immunosenescence and T-cell biology.
  • Analysis of T-cell phenotypes, markers, and functional changes associated with aging.
  • Examination of the role of senescent T cells in cancer pathogenesis and the tumor microenvironment.

Main Results:

  • Identified key age-associated alterations and markers in T cells.
  • Detailed mechanisms underlying T-cell senescence.
  • Highlighted the complex relationship between senescent T cells and tumor progression and immune evasion.

Conclusions:

  • Senescent T cells are implicated in both healthy aging and pathological conditions like cancer.
  • Targeting senescent T cells presents a potential therapeutic strategy for age-related diseases.
  • Modulating senescent T cells may enhance the efficacy of cancer immunotherapies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
693
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
67.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K